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This report describes a very simple method that facilitates the analysis of the functional activity of essential genes of
herpes simplex virus type 1 (HSV-1) in cell culture. The method, which depends on the use of complementing plasmids
containing a virus origin of replication (oriS) and a packaging signal (amplicon plasmids), was tested for its ability to detect
complementation of the defective HSV-1 CgalD42 virus, a UL42 null mutant, by amplicon plasmids carrying either wild-
type (pA-UL42) or mutated alleles (pA-DUL42) of the HSV-1 UL42 gene. In nonpermissive Vero cells transfected with
amplicon plasmid pA-UL42 and superinfected with the defective CgalD42 virus, both the plasmid and the helper genomes
were amplified and packaged, giving rise to a self-complementing amplicon/helper virus population able to disseminate and
to form lytic plaques in cell culture. These plaques were due to complementation and not to recombination between the
defective virus and the amplicon plasmid as confirmed by Southern blot analysis of individual plaques. No complementation
was observed by superinfection of cells transfected with the noncomplementing pA-DUL42 amplicon plasmid. Instead,
small foci were observed in cells transfected with plasmids which express wild-type UL42 but were unable to amplify or
to become packaged, and the few true lytic plaques that were observed in these systems resulted from the spread of
competent recombinant viruses. Results presented in this work indicate that (i) self-complementation between a defective
virus and an amplicon plasmid provides a strong and very sensitive method to assess functional activity of an HSV-1
essential gene in a one-step experiment and (ii) oriS-carrying plasmids could be instrumental in the production and selection
of recombinant HSV-1 vectors. q 1996 Academic Press, Inc.
struction of recombinant viruses, in which the gene underAnalysis of gene function in herpes simplex virus type
study is replaced by a different one, is time-consuming1 (HSV-1) very often involves complementation studies
and hard to achieve when the purpose is to analyze thein which a virus gene, which has been mutated or deleted
behavior of high numbers of mutated alleles.from the viral genome, is transcomplemented by wild-
In this study, we present a very simple method whichtype or mutated alleles. Different ways to provide the
combines the complementation properties of plasmidlacking function have been developed, and most of them
transfection with those of recombinant virus infection.have proved useful for selected applications. Most of
This method, which is based on the use of plasmidsthese approaches suffer, however, from several major
carrying HSV-1 origins of replication (oriS) and packagingdrawbacks. For example, using plasmid transfection,
signals (amplicon plasmids), significantly increases lev-transcomplementation is restricted to, and can be di-
els of complementation and may thus help in the resolu-rectly observed in, only those cells expressing the plas-
tion of the above described problems. Amplicons (15)mid, which generally results in an overall low level of
are shuttle vectors that can be genetically manipulatedcomplementation. The development of cell lines stably
in vitro and amplified as plasmids in Escherichia coli.transfected with the gene under study allows high-level
After being transfected into eukaryotic cells, and in thecomplementation of mutant viruses and has proved in-
presence of helper HSV-1 genomes that provide replica-valuable for genetic analysis. However, this approach is
tion and structural proteins, these plasmids are amplifiedlimited to specially constructed cell lines which express
and packaged, giving rise to a heterogeneous HSV-1the gene. Furthermore, this approach is problematic
population composed of both helper and defective parti-when the virus genes to be expressed by these cells
cles (2, 3, 16). Amplicon vectors have been used effi-encode proteins with cytotoxic properties. Finally, con-
ciently to complement functions lacking in particular tar-
get cells (1, 6– 8). This suggests that they could be used
to complement an essential HSV-1 function that is lack-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (33) 72 44 05 55. E-mail: epstein@biomserv.univ-lyon1.fr. ing in the helper target virus genome. The expression of
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both defective amplicon and helper genome within the i.e., pA-SF1 (lane 1), pA-UL42 (lane 3), and pA-DUL42
(lane 5) were propagated as amplicon vectors, whereassame cell may generate a self-complementing virus pop-
ulation in which each type of particle would carry the pUL42 (lane 2) and pO-UL42 (lane 4) were not, in spite
of the fact that the latter plasmid can be amplified by theessential gene(s) lacking in the other. This heteroge-
neous self-complementing virus population would be helper virus in origin-dependent replication assays (data
not shown).predicted to grow and self-perpetuate in many different
types of cells, which would otherwise be nonpermissive To study whether transcomplementation of defective
HSV-1 CgalD42 by an amplicon, expressing a functionalfor either type of particle, both in vitro and in vivo.
To test this idea, we have constructed an amplicon UL42 gene, could generate a self-perpetuating virus pop-
ulation, able to produce disseminating plaques, nonper-plasmid, pA-UL42, carrying the wild-type allele of the
HSV-1 UL42 gene, which encodes a gene product essen- missive Vero cells were independently transfected with
plasmids shown in Fig. 1 and superinfected with thetial for HSV-1 DNA replication (11). The plasmid was
tested for its ability to transcomplement the defective defective virus at a m.o.i. of 0.01 PFU/cell. Infections were
allowed to progress for 2 days in the presence of 1%HSV-1 CgalD42 (9), which is deleted for the UL42 gene
and can propagate only in UL42 trans-complementing carboxy-methyl cellulose (CMC) overlay, to avoid second-
ary infections, and cells were then fixed and stained withcell lines, such as V9 cells (9). Results reported in this
work show that the functional UL42 protein expressed the chromogenic substrate X-Gal. Foci of cells showing
cytopathic effects could be observed in the three Verofrom pA-UL42 plasmid efficiently complemented the
CgalD42 virus, leading to a self-complementing ampli- cultures transfected with plasmids expressing a func-
tional UL42 protein (pUL42, pO-UL42, and pA-UL42) ascon/helper virus population capable of rapid dissemina-
tion and complete destruction of nonpermissive Vero cell shown in Figs. 3B– 3D. However, in cell cultures
transfected with pA-DUL42, only isolated individual cellscultures. By contrast, only small foci were observed in
Vero cells transfected with either of two different comple- which colored blue in the presence of X-Gal (Fig. 3A)
were observed, as a result of expression of the lacZ genementing, nonamplicon plasmids, and no foci were ob-
served when using an amplicon expressing a nonfunc- from the input nonreplicating viral genome. Vero cells
transfected with plasmid pA-UL42 showed a significanttional allele of UL42.
We have constructed a set of plasmids (Fig. 1) carrying spread of the infection, in that most foci developed into
large lytic plaques (Fig. 3D). In contrast, in cellswild-type or mutated versions of the gene UL42 from
HSV-1. The reference plasmid carrying the wild-type transfected with either pO-UL42 or pUL42, most foci re-
mained restricted to a few cells (Figs. 3C and 3B). Thus,UL42 gene is pUL42, which expresses the wild-type gene
product. Two other plasmids carry, in addition to the wild- while complementation of the defective virus could be
observed with the three plasmids which express a func-type UL42 gene, a sequence containing oriS (pO-UL42)
or sequences containing both oriS and the cleavage/ tional UL42 protein, only the pA-UL42/CgalD42 system
gave rise to growing lytic plaques. This plaque assaypackaging signal a (amplicon pA-UL42). Plasmid pA-
DUL42 is identical to pA-UL42 except that the UL42 gene allowed us to distinguish between absence of comple-
mentation (the isolated blue cells infected with the defec-contains an internal PstI deletion that has been de-
scribed to abolish UL42 protein activity in vitro (5). Plas- tive virus in cells transfected by pA-DUL42), restricted
complementation (the foci of cells induced by pUL42 ormid pA-SF1 is a control b-galactosidase expressing plas-
mid that gives rise to amplicon vectors in the presence pO-UL42), and amplifying complementation (the dissemi-
nating plaques induced by pA-UL42). Moreover, theof wild-type helper HSV-1 (10). To test whether the differ-
ent cis-acting elements carried by the plasmids de- assay is sensitive enough to clearly identify fully comple-
menting plasmids in a one-step experiment, a propertyscribed in Fig. 1 were functional, we examined the ability
of each plasmid to behave as an amplicon. Parallel Vero that could be particularly useful when the defective virus
is not a ‘‘blue’’ one.cultures were transfected with each of the plasmids and
superinfected with competent HSV-1 Cgal/ (9) and infec- When infections were allowed to progress beyond 2
days, Vero cells that had been transfected with pA-UL42tions were allowed to progress until cytopathic effects
were complete. The resulting virus populations were then showed almost complete cytopathic effect by 5 days
postinfection, whereas in the case of cells transfectedfurther propagated two times on Vero cells at high multi-
plicity, as previously described (15). Twenty-four hours with either pUL42 or pO-UL42, most of the foci remained
restricted to a few cells by the same time. However,after the last infection, total DNA was extracted and di-
gested with XbaI restriction enzyme, transferred onto ny- several disseminating plaques were apparent in these
two cultures, with cultures transfected with pO-UL42lon membranes, and probed with labeled pSKII DNA
(Stratagene). Plasmids which are not amplified or are showing a higher number of these large plaques than
cultures transfected with pUL42 (data not shown).amplified but not packaged into virions would not be
expected to survive the serial passage. Figure 2 shows Plaques growing in Vero cultures transfected with pA-
UL42 could have resulted from the spread of a self-per-that plasmids carrying both the oriS and the a sequences,
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FIG. 1. Structure of the plasmids utilized in this study. Plasmids pA-SF1, pA-UL42, and pA-DUL42 carry one amplicon cassette (oriS and a
sequences) that has been cloned as a 3.4-kbp SacI fragment from pRB373 (13). Plasmids pUL42, pO-UL42, and pA-UL42 carry the HSV-1 UL42
gene under the control of its own promoter (pr42) (a 3.0-kbp ScaI/NsiI fragment from HSV-1). pA-SF1 carries a fusion gene encoding a protein
(Phleo-Lac) with both phleomycin resistance and b-galactosidase activities (10). Plasmid pO-UL42 was derived from pA-UL42 by EcoRI digestion
and religation; this plasmid carries an oriS sequence but not the a signal. Plasmid pUL42 carries neither oriS nor a sequences. In plasmid pA-
DUL42, the arrow representing UL42 is hatched to indicate that the gene contains an internal PstI deletion that has been described to abolish
UL42 activity in vitro (5). Other abbreviations are SV40, early and late regulatory sequences from SV40; IE-HCMV, human cytomegalovirus immediate –
early enhancer and promoter; poly A, splicing and polyadenylation signals from SV40; UL41 and UL43, amino-terminal portions of HSV-1 UL41 and
UL43 genes. Sequences in black represent the bacterial ColE1 origin and ampicilin resistance gene from the pSKII plasmid. Restriction cloning
sites are also shown.
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ated from homologous recombination between the plas-
mids and the defective virus, at the UL42 locus. In con-
trast, all plaques taken from Vero cells transfected with
pA-UL42 showed a restriction profile corresponding to
the defective CgalD42 virus (Fig. 4A, tracks 2 to 5), indi-
cating that among the plaques analyzed, no revertant
recombinant viruses were detected and suggesting that
these plaques contained both defective virus and com-
plementing amplicon particles. To confirm whether this
was the case, total DNA from individual plaques was
digested with XbaI, blotted onto nylon membranes, and
hybridized with labeled pSKII DNA. Figure 4B (tracks 2
to 4) shows that, for plaques taken from Vero cells
transfected with pA-UL42, a 8.6-kbp fragment was gener-
ated, similar in size to that produced by digestion of
parental pA-UL42 plasmid (track 1). This result wouldFIG. 2. Amplification and packaging of plasmids employed in this
study. Vero cells were transfected with indicated plasmids and superin- be expected only if infected cells contained amplicon
fected with HSV-1 Cgal/ 18 hr later. When CPE was 100%, cells were vectors. Furthermore, two shorter, underrepresented
scrapped, pelleted by centrifugation at low speed, suspended in 1 ml fragments, of about 6.6 and 2.0 kbp, were also observed,
PBS, and frozen and thawed three times. Virus populations were then
probably corresponding to the ends of the encapsidatedpassaged two more times in Vero cells, employing about 50% of the
concatemers. No hybridization with pSKII DNA was ob-samples each time. Twenty-four hours after the third passage, infec-
tions were stopped and total DNA from infected cells was extracted. served with the DNA extracted from plaques taken from
DNA samples were then treated with XbaI and DpnI restriction en- Vero cells transfected with plasmids pUL42 or pO-UL42
zymes, and digestion fragments were electrophoretically separated in (Fig. 4B, tracks 5 to 8), further confirming that these
0.7% agarose gels in TBE buffer, transferred to nylon membranes, and
plaques contained virus which had recombined only athybridized with [32P]dCTP-labeled pSKII DNA. Lanes 1 to 5: cells were
the UL42 locus. Taken together, these results indicatetransfected with pA-SF1, pUL42, pA-UL42, pO-UL42, and pA-DUL42,
respectively. Lane 6: cells were transfected only with carrier DNA be- that most plaques observed in the Vero cultures
fore superinfection. transfected with plasmid pA-UL42 and superinfected with
CgalD42 defective virus originate from the spread of a
virus population containing both complementing ampli-
petuating amplicon population, as we hypothesized, or con and defective helper particles.
from the replication of competent particles generated by In order to quantitatively compare levels of comple-
recombination between the plasmid and viral genomes. mentation in the different transfected cultures, the virus
Plaques growing in Vero cells transfected with the non- populations produced by 2 days postinfection were ti-
replicating (pUL42) or nonencapsidating (pO-UL42) plas- trated by plaque assay, both on permissive V9 cells and
mids were expected to arise exclusively from recombina- on nonpermissive Vero cells. After 4 days in 1% CMC
tion. To study whether the plaques observed in cells media, plaques were scored in both types of cells. Values
transfected with pA-UL42 arose mainly by complementa- obtained in permissive V9 cells, which represent mainly
tion or by recombination, Vero cells were independently CgalD42 virus titers, indicate that more virus was pro-
transfected with plasmids pUL42, pO-UL42, or pA-UL42 duced in the pA-UL42-transfected Vero cells than in pO-
and superinfected with CgalD42 virus as before. Several UL42- or in pUL42-transfected cells (1.3 1 105 PFU/ml
individual plaques were picked from each of the cultures versus 3.3 1 104 and 2.7 1 104 PFU/ml, respectively). As
and submitted to genetic analysis. Total DNA from each expected, no virus was produced in Vero cells
plaque was extracted by standard methods (14), digested transfected with either pA-SF1 or pA-DUL42. These re-
with restriction enzyme NsiI, and analyzed by Southern sults confirm in quantitative terms that the self-perpetuat-
blots, using labeled genomic HSV-1 DNA as a probe. ing system is stronger and more sensitive than the stan-
NsiI cuts the viral genome at both the UL40 and the UL43 dard complementation system in assessing complemen-
genes, at positions 90,368 and 94,988, respectively (12), tation of an essential virus function.
generating a 4.6-kbp fragment which contains the entire Interestingly, the virus produced in the cultures
UL42 gene, greatly facilitating discrimination between transfected with pO-UL42 showed a titer in Vero cells
parental HSV-1 Cgal/ (Fig. 4A, lane 1) and the isogenic that was about two orders of magnitude higher than that
deleted mutant CgalD42 (Fig. 4A, lane 11). The DNA of the virus produced in pUL42-transfected cells (1.8 1
restriction profiles from plaques picked from Vero cells 103 and 1.5 1 101, respectively), suggesting that pO-UL42
transfected with pO-UL42 (lanes 6 to 9) or pUL42 (lane plasmid gave rise to much more competent recombi-
10) corresponded to that of Cgal/ virus, demonstrating nants than did pUL42 plasmids. The virus produced in
pA-UL42-transfected Vero cells also gave rise to plaquesthat these plaques contained, as expected, virus gener-
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FIG. 3. Cytopathic effects induced in Vero cell cultures transfected with the different plasmids and superinfected with HSV-1 CgalD42, which
contains a lacZ gene under the control of the HCMV immediate– early promoter and a large deletion of UL42 gene sequences. Semiconfluent Vero
cells (80% confluence) were transfected with plasmids pUL42, pO-UL42, pA-UL42, or pA-DUL42 (10 mg each). Eighteen hours later, transfected
cells were infected at very low m.o.i. (0.01 PFU/cell) with defective HSV-1 CgalD42 virus. After discarding nonadsorbed virus, cells were washed
and 199 medium supplemented with 1% heat-inactivated FCS and carboxy-methyl cellulose to 1% final concentration was added. Two days after
infection, cells were fixed with glutaraldehyde and stained with the chromogenic substrate X-Gal. (A, B, C, and D) Vero cells were transfected with
pA-DUL42, pUL42, pO-UL42, and pA-UL42, respectively.
when titrated in Vero cells, but Southern blot analysis of the couple CgalD42/pA-UL42 behaved as a replication-
competent virus, illustrating the fact that a self-comple-a dozen plaques showed that, as before, they contained
amplicon and defective virus particles but not recombi- menting amplicon system can be used in the place of a
recombinant virus for the analysis of a genetic function.nants (data not shown).
This work thus demonstrates that an amplicon vector The improved sensitivity of the self-complementing
system was not only assessed directly by plaque forma-expressing an essential HSV-1 function can be amplified
and packaged by a helper virus defective for that func- tion in a one-step experiment in nonpermissive cells, but
also by quantifying yields of defective CgalD42 virus intion, giving rise to a composite virus population that be-
haves like a self-complementing and amplifying system. permissive V9 cells. This showed that more virus was
produced in Vero cells transfected with pA-UL42 than inBecause of the presence of the complementing amplicon
particles, the defective CgalD42 virus could spread, form cells transfected with the other complementing plasmids.
Genetic analysis of HSV-1 essential genes by comple-plaques, and finally destroy otherwise nonpermissive
Vero cultures. While the couple CgalD42/pA-DUL42 be- mentation of a defective virus with plasmids containing
wild-type or mutated alleles currently requires titration ofhaved in nonpermissive Vero cells like a defective virus,
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licating plasmids because they enter cells through infec-
tion and express the complementing function from a con-
text that is more like that of the virus genome.
In the course of these studies we observed that pO-
UL42 gave rise to about two orders of magnitude more
competent recombinants than did pUL42, as assessed
by their ability to form plaques in Vero cells and con-
firmed by molecular hybridization. The only structural dif-
ference between pUL42 and pO-UL42 is the presence of
one oriS sequence in pO-UL42. Our results thus suggest
that the high increase in the number of recombinants,
from 15 with pUL42 to about 1800 with pO-UL42, is a
consequence of the coamplification of the virus and plas-
mid genomes in the same cell. The fact that pO-UL42
gave more recombinants than pUL42 is not in itself sur-
prising, since it is well known that HSV-1-directed repli-
cation is recombinogenic, a fact that has been studied
mainly at the level of plasmid rearrangements (17). Re-
sults shown here suggest that oriS-carrying plasmids
could be instrumental in the production and selection of
recombinant HSV-1 vectors.
It is interesting to discuss the failure to detect recombi-
nants in the case of the amplicon plasmid-transfected
Vero cells infected with the defective virus. The only dif-
ference between pO-UL42 and pA-UL42 is the presence,
in the latter plasmid, of a short EcoRI fragment containing
the cleavage/encapsidation a signal, as well as some
adjacent b and c sequences (13). These sequences haveFIG. 4. Genetic structure of viruses able to form plaques in Vero cell
been described to be highly recombinogenic, promotingcultures. Vero cultures were transfected with the different plasmids
inversions or deletions inside replicating HSV-1 ge-and infected with HSV-1 CgalD42 as described in the legend to Fig.
3. Growing lytic plaques were taken from the different cultures and nomes or plasmids containing a viral origin of replication
total DNA for each was extracted. (A) Aliquots of total DNA were di- (4, 17). Thus, one possibility that we cannot rule out at
gested with NsiI and restriction fragments were electrophoretically sep- present is that these sequences in the replicating ampli-arated in 0.7% agarose, blotted onto nylon membranes, and probed
con genome could divert and exhaust proteins involvedwith [a-32P]dCTP-labeled virus genomes. Lanes 1 and 11: control Vero
in recombination, resulting in limited recombination atcells infected with HSV-1 Cgal/ or HSV-1 CgalD42, respectively. Lanes
2 to 10: restriction profiles of the DNA from plaques taken from Vero the UL42 locus. A second possibility is that through re-
cultures that had been transfected with pA-UL42 (lanes 2 to 5), pO- combination at the bac sequences, copies of the UL42
UL42 (lanes 6 to 9), or pUL42 (lane 10) before superinfection with HSV-
gene could be introduced at ectopic sites. This possibility1 CgalD42. (B) Aliquots of total DNA were digested with XbaI restriction
seems unlikely, however, since all plaques examined didenzyme. After separation and transfer to nylon membranes, as before,
contained CgalD42 like-viruses and pA-UL42 amplicons,restriction fragments were probed with [a-32P]dCTP-labeled pSKII DNA.
Lane 1: plasmid pA-UL42 alone. Lanes 2 to 8: restriction profiles of and we observed no evidence of rearranged virus ge-
the DNA contained in plaques taken from Vero cells that had been nomes. Alternatively, it is possible that pA-UL42 did in
transfected with pA-UL42 (lanes 2 to 4), pO-UL42 (lanes 5 to 7), or fact generate as many competent recombinants as didpUL42 (lane 8), before superinfection with HSV-1 CgalD42. Arrows
pO-UL42. In this case, the most likely explanation forindicate two underrepresented bands that hybridize with plasmid DNA,
our failure to readily detect recombinants from the self-that are absent in lane 1, and probably represent the ends of packaged
concatemers. perpetuating system would be that recombinants gener-
ated using this system will have little or no selective
replication advantage over the defective genomes be-the defective virus to assess the trans-complementation
cause of the simultaneous presence of the complement-ability of each allele. In our assay, plaque formation
ing amplicon. Number of recombinants would be ex-allows direct determination of the functionality of the
pected to remain low in this case, at least under theUL42 protein in infected cells. Furthermore, this test
experimental conditions described in this report. By con-could be used to rapidly identify and select alleles that
trast, in the case of the two nonamplicon plasmids, com-allow different levels of replication of the defective virus,
petent recombinants, even if generated by a similar lowprior to the construction of recombinant genomes con-
frequency, will be able to expand in nonpermissive cellstaining these alleles. Self-complementing amplicons are
also more reliable in complementation tests than nonrep- and will be easily selected.
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